Publication | Closed Access

Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model

Knockout MouseGene TherapiesEffective SuppressionGeneticsImmunologyClinical DosesGenetic EngineeringMutagenesisGene TransferMedicineGenetic MedicineMolecular MedicineDrug Resistance